Erika Trahan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Erika trahan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Erika Trahan Today - Breaking & Trending Today

Novavax to Present COVID-19 Vaccine Candidate Data at New York Academy of Science


Novavax to Present COVID-19 Vaccine Candidate Data at New York Academy of Science
SYNDICATED 1 months ago
GAITHERSBURG, Md., Feb. 01, 2021 (GLOBE NEWSWIRE) Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Gregory M. Glenn, M.D, President of Research & Development, will present on NVX-CoV2373, the company’s COVID-19 vaccine, at The New York Academy of Science (NYAS) event, ‘The Quest for a COVID-19 Vaccine.’ Webinar details are as follows: Presentation title:Efficacy Data Updates from Novavax’ Protein-based Vaccine CandidateDate:February 2, 2021Time:4:00 pm ETPresenter:Dr. Glenn Novavax announced interim data last week on its protein-based COVID-19 vaccine candidate that demonstrated efficacy of 89.3% in a pivotal Phase 3 clinical trial taking place in the United Kingdom (UK). The data from this UK Phase 3 trial and a South Africa Phase 2b study were the first to demon ....

United Kingdom , South Africa , Glenn Novavax , Gregorym Glenn , Erika Trahan , Jennifer Porcelli , Novavax Inc , Research Development , Exchange Commission , York Academy Of Science , New York Academy , Efficacy Data Updates , Novavax Protein Based Vaccine Candidatedate , United Kingdom Phase , South Africa Phase , About Matrix M , Novavax Forward Looking Statements , Novavax Annual Report , Quarterly Report , Investors Erika Trahan , Trout Jennifer Porcelli , Amy Speak , ஒன்றுபட்டது கிஂக்டம் , எரிகா திர்ன் , ஜெனிபர் போர்செல்லி , ஆராய்ச்சி வளர்ச்சி ,

Novavax Announces Memorandum of Understanding to Produce COVID-19 Vaccine Made in Canada


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Novavax Announces Memorandum of Understanding to Produce COVID-19 Vaccine Made in Canada
Novavax, Inc.February 2, 2021 GMT
GAITHERSBURG, Md., Feb. 02, 2021 (GLOBE NEWSWIRE) Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced memorandum of understanding with the Canadian government to produce NVX-CoV2373, the Company’s protein-based vaccine candidate against COVID-19 in Canada.
“Since the beginning of the pandemic, our top priority has been the health and safety of all Canadians,” said Prime Minister Justin Trudeau. “Today, we are investing in our biomanufacturing capacity so that we have the made-in-Canada vaccines and treatments we need to protect Canadians, now and in the future, and recover from the impacts of COVID-19.” ....

South Africa , Laura Keenan , Justin Trudeau , Stanleyc Erck , Erika Trahan , Exchange Commission , National Research Council Royalmount , Health Canada , Novavax Inc , Prime Minister Justin , Chief Executive Officer , National Research Council , Biologics Manufacturing Centre , Philippe Champagne , Novavax Annual Report , Quarterly Report , லாரா கீநெந் , ஜஸ்டின் திருடேௌஉ , எரிகா திர்ன் , பரிமாற்றம் தரகு , ஆரோக்கியம் கனடா , ப்ரைம் அமைச்சர் ஜஸ்டின் , தலைமை நிர்வாகி அதிகாரி , தேசிய ஆராய்ச்சி சபை , உயிரியல் உற்பத்தி மையம் , பிலிப் ஷாம்பெயின் ,

Novavax and Government of Canada Finalize Advance Purchase Agreement for COVID-19 Vaccine


Novavax and Government of Canada Finalize Advance Purchase Agreement for COVID-19 Vaccine
Canadian government commits to purchase 52 million doses with option for additional 24 million of Novavax candidate vaccine, NVX-CoV2373
January 22, 2021 17:23 ET
| Source:
Novavax, Inc.
Novavax, Inc.
Gaithersburg, Maryland, UNITED STATES
GAITHERSBURG, Md., Jan. 22, 2021 (GLOBE NEWSWIRE) Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has finalized an agreement with the Government of Canada to supply up to 76 million doses of NVX-CoV2373, the company’s recombinant protein-based COVID-19 vaccine. Canada has committed to purchase 52 million doses of the vaccine with the option for up to an additional 24 million doses. NVX-CoV2373 is currently in Phase 3 clinical development for the prevention ....

South Africa , Edna Kaplan , Erika Trahan , Johnj Trizzino , Exchange Commission , Novavax Inc , Chief Commercial Officer , Chief Business Officer , Novavax Annual Report , Quarterly Report , Investors Erika Trahan , Nasdaq Nvax , Covid 19 Vaccine , Corona Virus , எட்னா கபிலன் , எரிகா திர்ன் , பரிமாற்றம் தரகு , தலைமை வணிகரீதியானது அதிகாரி , தலைமை வணிக அதிகாரி , காலாண்டு அறிக்கை , முதலீட்டாளர்கள் எரிகா திர்ன் , கொரோனா வைரஸ் ,

Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer
Novavax, Inc.January 15, 2021 GMT
GAITHERSBURG, Md., Jan. 15, 2021 (GLOBE NEWSWIRE) Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Henrietta Ukwu, M.D., FACP, FRAPS, to the position of Senior Vice President, Chief Regulatory and Quality Officer. In this newly created role, Dr. Ukwu will lead global regulatory strategy and execution as well as the quality assurance function for the company’s development-stage vaccine candidates, including its recombinant protein-based COVID-19 candidate vaccine, NVX-CoV2373. ....

Baptist Hospital , United States , Vanderbilt University , Edna Kaplan , Henrietta Ukwu , Stanleyc Erck , Erika Trahan , Merck Co Inc , Head Of Global Regulatory Affairs , Novavax Inc , University Of Jos School Medicine , Otsuka Pharmaceuticals , Regulatory Affairs , Head Of Vaccine Regulatory Development , Wyeth Pharmaceuticals Inc , American College Of Physicians , Exchange Commission , Global Regulatory Affairs , Regulatory Affairs Professional Society , Senior Vice President , Chief Regulatory , Chief Executive Officer , Chief Regulatory Officer , Global Head , Wyeth Pharmaceuticals , Vice President ,